Market Tracker

06/09 5:38pm ET

Novo Nordisk A/S (NYSE:NVO)

Delayed Data
As of Jun 09
 -1.38 / -0.87%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 23 analysts offering 12-month price forecasts for Novo Nordisk A/S have a median target of 180.13, with a high estimate of 208.80 and a low estimate of 103.69. The median estimate represents a +13.96% increase from the last price of 158.07.

Analyst Recommendations

The current consensus among 27 polled investment analysts is to Buy stock in Novo Nordisk A/S. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -1.33%
Growthannually 43.06%


Growthquarterly -0.52%
Growthannually 25.13%
Key to the earnings and sales forecast charts.